Changes in Immune Activation in the T Cell Compartments of HIV HCV Coinfected Patients During PEG IFN RBV Treatment

Retrovirology - United Kingdom
doi 10.1186/1742-4690-9-s1-p56
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Changes in T-Cell Subsets in HIV–HCV-coinfected Patients During Pegylated Interferon-Α2a Plus Ribavirin Treatment

Antiviral Therapy
Infectious DiseasesPharmacology
2010English

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2009English

Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV Co-Infected Patients: Implications for Treatment Outcomes

Journal of Hepatology
Hepatology
2010English

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection

PLoS ONE
Multidisciplinary
2013English

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

HIV Clinical Trials
2009English

HCV Monoinfection and HIV/HCV Coinfection Enhance T-Cell Immune Senescence in Injecting Drug Users Early During Infection

Immunity and Ageing
AgingImmunology
2016English

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Barriers to Treatment of Hepatitis C in HIV/HCV Coinfected Adults in Brazil

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2010English

Patient-Reported Symptoms During Direct-Acting Antiviral Treatment: A Real-Life Study in HIV-HCV Coinfected Patients (ANRS CO13 HEPAVIH)

Journal of Hepatology
Hepatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy